Search results
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 3 hours agoDespite a bevy of promising updates for its cancer treatments, Pfizer stock remains trapped below a...
2 Dividend Stocks Billionaires Are Buying: Should You?
The Motley Fool via AOL· 1 hour agoIt's essential to do some research of our own. With that said, let's look at two dividend stocks that at least a couple of billionaires bought during the last quarter: Pfizer
Updated Covid-19 Vaccine Targeting JN.1 Recommended By FDA Panel
Forbes· 2 days agoThe Vaccines and Related Biological Products Advisory Committee of the FDA evaluated the...
Pfizer (NYSE:PFE) Trading 0.3% Higher
ETF DAILY NEWS· 1 day agoPfizer Inc. (NYSE:PFE – Get Free Report) traded up 0.3% during mid-day trading on Tuesday . The company traded as high as $29.73 and last traded at $29.41. 9,834,266 shares ...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 2 hours agoUsually, RSV causes coldlike symptoms in most people. But in newborns and older adults it can be...
Pfizer Stock: Surging Cancer Rates Will Boost Revenues (NYSE:PFE)
Seeking Alpha· 6 hours agoAnalyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the...
Why Things Could Get Worse for Pfizer Stock Before They Get Better | The Motley Fool
The Motley Fool· 2 days agoA few years ago, in the race to launch a COVID-19 vaccine, Pfizer (PFE 0.20%) stock was a hot buy...
Is Pfizer Inc. (NYSE:PFE) the Best Gene Therapy Stock to Buy Now?
Insider Monkey via Yahoo Finance· 4 days agoWe recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we...
Is Pfizer the Best Dividend Stock for You?
Motley Fool via Yahoo Finance· 6 days agoThe pandemic-influenced revenue gusher from which pharmaceutical giant Pfizer (NYSE: PFE) benefitted a few years ago has trickled down to a small stream....
Pfizer: New Cancer Drugs Could Breathe New Life Into Struggling Pharma Behemoth
Investing.com· 3 days agoPharmaceutical stocks, once pandemic favorites, have faced significant corrections. Despite broader...